Skip to main content
Database: The Journal of Biological Databases and Curation logoLink to Database: The Journal of Biological Databases and Curation
. 2021 Oct 13;2021:baab065. doi: 10.1093/database/baab065

HBFP: a new repository for human body fluid proteome

Dan Shao 1,2,3, Lan Huang 4, Yan Wang 5,*, Xueteng Cui 6, Yufei Li 7, Yao Wang 8, Qin Ma 9, Wei Du 10, Juan Cui 11,*
PMCID: PMC8516408  PMID: 34642750

Abstract

Body fluid proteome has been intensively studied as a primary source for disease biomarker discovery. Using advanced proteomics technologies, early research success has resulted in increasingly accumulated proteins detected in different body fluids, among which many are promising biomarkers. However, despite a handful of small-scale and specific data resources, current research is clearly lacking effort compiling published body fluid proteins into a centralized and sustainable repository that can provide users with systematic analytic tools. In this study, we developed a new database of human body fluid proteome (HBFP) that focuses on experimentally validated proteome in 17 types of human body fluids. The current database archives 11 827 unique proteins reported by 164 scientific publications, with a maximal false discovery rate of 0.01 on both the peptide and protein levels since 2001, and enables users to query, analyze and download protein entries with respect to each body fluid. Three unique features of this new system include the following: (i) the protein annotation page includes detailed abundance information based on relative qualitative measures of peptides reported in the original references, (ii) a new score is calculated on each reported protein to indicate the discovery confidence and (iii) HBFP catalogs 7354 proteins with at least two non-nested uniquely mapping peptides of nine amino acids according to the Human Proteome Project Data Interpretation Guidelines, while the remaining 4473 proteins have more than two unique peptides without given sequence information. As an important resource for human protein secretome, we anticipate that this new HBFP database can be a powerful tool that facilitates research in clinical proteomics and biomarker discovery.

Database URL: https://bmbl.bmi.osumc.edu/HBFP/

Background

Human body fluids are thought to be rich resources of disease-associated proteins that are secreted or leaked from pathological tissues across the body, many of which are commonly obtainable through non-invasive procedures (1, 2). Driven by these factors, research interests have soared a few decades ago toward biomarker discovery by examining body fluid proteomes. It is highly plausible that empowered by innovative high-throughput technologies, modern proteomic studies have successfully identified a large number of proteins in various body fluids such as plasma, serum, saliva and urine (3).

With great effort by a few large consortiums, several community-based proteomic databases have been developed in the past decades. For example, in 2002, the international Human Proteome Organization initiated the Human Plasma Proteome Project and reported human plasma and serum protein constituents in its online databases (4). Another similar database, named Plasma Proteome Database, archived more than 10 000 proteins detected in human blood (5). Additionally, the Proteomics Identifications database (6) and Human Plasma PeptideAtlas (7) report a total of 3509 high-confidence plasma proteins. More recently, the extracellular vesicles community also reports new proteins identified in exosomes in multiple different resources including blood and breast milk, e.g. in ExoCarta (8). Additionally, the global Human Proteome Project (HPP) announces a set of mass spectrometry (MS) data interpretation guidelines that are presented to the broader research community (9).

Our team has recently conducted a systematical assessment of human proteome identified using quantitative proteomics tools such as MS and computational predictive models, as documented in a recent review article (10). To expand this effort, we developed a new human body fluid proteome (HBFP) database to organize 11 827 unique proteins reported in 164 scientific articles since 2001, which has a maximal false discovery rate (FDR) of 0.01 on both the peptide and protein levels. Until today, this database stores information about proteins from 17 types of body fluids including plasma/serum, saliva, urine, cerebrospinal fluid (CSF), seminal fluid (SF), amniotic fluid, tear fluid, bronchoalveolar lavage fluid (BALF), milk, synovial fluid, nipple aspirate fluid, cervical-vaginal fluid, pleural effusion, sputum, exhaled breath condensate, pancreatic juice and sweat. For each protein entry, description about protein secretion information, literature source, abundances, confidence and functional annotation is provided. This database system also provides users easy access to data visualization and download and functional analysis based on Gene Ontology (GO) and pathways.

Database content and design

Protein entries

We have manually collected proteins reported in 17 types of body fluids by carefully reviewing 164 scientific references published since 2001 based on a PubMed search with FDR ≤1% on both the peptide and protein levels.

In the HBFP database, each protein is assigned with a unique identifier of UniProtKB/Swiss-Prot accession (UniProt release 2020_06) (11). Since different identifiers have been mixed used in the referenced studies, we first used conversion tools at BioDBnet (https://biodbnet-abcc.ncifcrf.gov/) (12) and UniProt (https://www.UniProt.org/) to confidently convert different identifiers to UniProt accession numbers. The common identifiers involved in this study include International Protein Index ID [hosted at European Bioinformatics Institute (EBI) (closed in 2011)], GI number (from Genbank database), RefSeq protein accession (from RefSeq database), Gene name/symbol (from NCBI Gene database) and UniProt protein/entry name (from UniProt database). The ID conversion process is shown in Figure 1. During the conversion, poorly curated proteins with ambiguous identifiers were eliminated. For examples, many International Protein Index ID links to unclearly described instances that cannot be mapped to a UniProt entry are excluded.

Figure 1.

Figure 1.

Workflow of protein identifier conversion.

Database utilities

The interface of the HBFP database is constructed by PHP, while the database system is based on MySQL. The main contents of the current database include query and browse pages described as follows.

Querying page

As one of the most important functions, the querying page allows users to search for body fluid proteins based on different types of input including protein ID, gene name, and protein or gene sequence. When given a FASTA input, BLASTp or BLASTn is used to translate sequence input to the best-match protein entry. The top hit (the highest bit score) from the BLAST search is considered the best match of the query. Figure 2 illustrates the workflow and content of querying page.

Figure 2.

Figure 2.

Construction workflow and utilities of querying page.

The annotation of each protein contains the following information:

  • Protein ID/name/entry name

  • Gene name

  • Associated body fluid type along with indicated discovery confidence (explained in the next section)

  • References and protein abundance information where the protein is reported

  • External links to public databases including UniProt, PeptideAtlas and NeXtProt (13), MassIVE (14)

  • Functional annotation based on the KEGG pathway (15) and GO (16)

Browsing page

This page provides an overview list of proteins associated with 17 types of body fluids and links to view and download selected proteins.

Database highlights

Data statistics

When determining the inclusion of reported proteins, we applied the following criteria for credibility of the MS evidence. First, for papers that issued peptide sequence details, we remapped all those peptide sequences to neXtProt (release 2021-02-15) using the neXtProt peptide uniqueness checker to remove unreliable matches (17). Specifically, we applied guideline #15 of HPP Guidelines 2.1 (9) to include proteins that contain at least two non-nested uniquely mapping peptides of nine amino acids into the HBFP database. According to this criterion, 7354 proteins were confirmed confidently. Another 4473 proteins were also included as they were not explicitly provided with peptide sequence information but have more than two unique peptides.

The overall statistics about the protein entries and references in terms of each body fluid are summarized in Table 1. The current HBFP database contains 11 827 distinct proteins from 17 types of body fluids. Note that urine exceeds all other body fluids in terms of protein counts while blood is at the second rank. All data are made publicly available in the HBFP and via links at https://bmbl.bmi.osumc.edu/HBFP/.

Table 1.

Overall statistics

Statistics
Body fluid types Number of protein entries Number of references References
1 Plasma/serum 5790 38 (18–55)
2 Saliva 2758 21 (19, 56–75)
3 Urine 7330 23 (19, 76–97)
4 CSF 4364 12 (19, 90, 98–107)
5 SF 4084 5 (108–112)
6 Amniotic fluid 3025 6 (19, 113–117)
7 Tear fluid (TF) 1882 11 (118–128)
8 BALF 3434 6 (41, 129–133)
9 Milk 2457 14 (134–147)
10 Synovial fluid 1637 7 (148–154)
11 Nipple aspirate fluid 1734 5 (155–159)
12 Cervical–vaginal fluid 949 4 (160–163)
13 Pleural effusion 1519 3 (164–166)
14 Sputum 1809 3 (167–169)
15 Exhaled breath condensate 351 5 (170–174)
16 Pancreatic juice 702 4 (175–178)
17 Sweat 1244 3 (179–181)
Total (non-redundant) 11 827 164

Protein abundance

In order to provide users experimental evidence from the original study, this database also displays relatively abundant information from the corresponding literature studies. General proteomics approaches using MS identify proteins by matching identified peptides against predefined protein sequence databases. The qualitative measures of protein reported in the original reference include the following: (i) peptide information: most of cited studies provide explicit information about peptide sequence, the total number of peptides, MS counts or the percent sequence coverage; (ii) differential expression information including fold change (positive value demonstrates up-regulated expression and negative value indicates down-regulated expression), up- or down-regulated expression in case vs. control or (normalized) spectral counts and (iii) other statistical information including FDR, relative standard deviation and the number of times across different samples or experiments, as shown in Figure 3.

Figure 3.

Figure 3.

Distribution of protein abundance methods in HBFP database based on a number of original quantitative analysis methods from the original literature studies. Note that the sum of protein abundance is not 100% since not all of the literature studies provide quantitative analysis information.

Confidence score

In the HBFP database, to evaluate the confidence level of each discovered protein in each body fluid, a new statistical measure is calculated based on Guideline # 9 of HPP guidelines 2.1 for the combined datasets. It is a well-known phenomenon that when taking N datasets with a substantial FDR and piling them all together, the overall FDR increases with the number of datasets. For example, for plasma, there are 38 papers with plasma protein lists, each with a substantial FDR (Inline graphic1%). It is probably a conservative estimate to suppose that the FDR of such a combined result is 1% + 0.5%Inline graphic(N datasetsInline graphic1) (9). It means that 50% of the correct identifications overlap and none of the incorrect ones does, so the resulting FDR is added in a 0.5% increment. Meanwhile, the confidence level of protein in the combined datasets is also reduced. Otherwise, considering the overlap of the true positives, the larger the number of datasets in which a protein is associated with a specific fluid, the more reliable this protein is. In the end, a confidence score Inline graphic is calculated as follows:

graphic file with name M5.gif (1)
graphic file with name M6.gif (2)
graphic file with name M7.gif (3)

where Inline graphic is the number of relevant literature studies (datasets) of a specific fluid Inline graphic; Inline graphic represents the overall FDR of multiple datasets in body fluid Inline graphic; Inline graphic means the confidence level of proteins in the combined datasets of body fluid Inline graphic and Inline graphic refers to the number of literature studies in which a protein Inline graphic is identified in body fluid Inline graphic.

For example, there are 38 literature studies related to blood in the HBFP, so Inline graphic, Inline graphic and Inline graphic. The protein O14791 is identified in blood by 19 independent studies, i.e. Inline graphic. As a result, the calculated Inline graphic score for O14791 in blood is Inline graphic. Meanwhile, protein Q9UJV9 only is identified in one paper for blood, so Inline graphic and Inline graphic. It means that protein Q9UJV9 maintains only the confidence level in the combined datasets of blood. Specifically, protein P01833 is identified in milk by 14 studies, and a total of 14 literature studies on milk are included in the HBFP, so protein P01833 maintains the original confidence level, i.e. 0.99. The larger the Inline graphic score, the higher the confidence that a protein reported in that fluid will be. Note that this score can only be compared within the same type of body fluid.

Database applications

Data access

The website can be accessed through https://bmbl.bmi.osumc.edu/HBFP/.

Query

All proteins can be easily accessed by searching protein ID, gene name, protein sequence (FASTA) or gene sequence (FASTA) (<50 items per query) (Figure 4A and B as an example). A BLAST (182) is performed locally to find the best match when the sequence FASTA format is given. For each protein, detailed information is displayed (Figure 4C). Users can connect directly to the PubMed or Google Scholar to view the original study through the provided links. Four databases (UniProt, PeptideAtlas, NeXtProt and MassIVE) are cross-linked for additional protein annotation, while the KEGG pathway and GO are focused on the functional aspects (Figure 4D).

Figure 4.

Figure 4.

Example of query response with input as ‘P58340’ in the protein ID and protein sequence box.

Download

HBFP allows users to browse the entire protein list in each body fluid, where the proteins are ordered based on descending confidence scores. Users can check and download all entries of the selected body fluid type in one go, as shown in Figure 5.

Figure 5.

Figure 5.

Download illustration where user can choose the body fluid name and download the proteins of interest or all proteins.

Demo of comparative analysis using the HBFP database

Body fluid analysis

Many proteins in the HBFP database have a broad distribution in terms of body fluid types. An internal comparative analysis across different fluids can provide further information regarding the specificity of a proposed marker protein. Of 11 827 identified proteins, 66.8% are identified in at least two body fluids (Figure 6). A total of 93 proteins (0.79%) are shared among all analyzed body fluids, which may indicate that these proteins are essential for various life activities (Table 2).

Figure 6.

Figure 6.

Comparative analysis across different body fluids. Seven thousand eight hundred and ninety-nine (7899) proteins are presented in at least two body fluids and 5733 proteins existed in at least three body fluids. Only 93 proteins exist in all 17 body fluids.

Table 2.

List of 93 proteins shared among all 17 body fluids

UniProt accession number Protein name Gene name
1 P11021 Endoplasmic reticulum chaperone BiP HSPA5
2 P55072 Transitional endoplasmic reticulum ATPase VCP
3 P13647 Keratin, type II cytoskeletal 5 KRT5
4 O00299 Chloride intracellular channel protein 1 CLIC1
5 P02787 Serotransferrin TF
6 P22314 Ubiquitin-like modifier-activating enzyme 1 UBA1
7 P13645 Keratin, type I cytoskeletal 10 KRT10
8 P02533 Keratin, type I cytoskeletal 14 KRT14
9 P07237 Protein disulfide-isomerase P4HB
10 P06576 ATP synthase subunit beta, mitochondrial ATP5F1B
11 P30041 Peroxiredoxin-6 PRDX6
12 P63104 14-3-3 protein zeta/delta YWHAZ
13 P62258 14-3-3 protein epsilon YWHAE
14 P14923 Junction plakoglobin JUP
15 P04040 Catalase CAT
16 P01834 Immunoglobulin kappa constant IGKC
17 P06702 Protein S100-A9 S100A9
18 P52209 6-Phosphogluconate dehydrogenase, decarboxylating PGD
19 P18669 Phosphoglycerate mutase 1 PGAM1
20 P14618 Pyruvate kinase PKM PKM
21 P61981 14-3-3 protein gamma YWHAG
22 P07384 Calpain-1 catalytic subunit CAPN1
23 P50395 Rab GDP dissociation inhibitor beta GDI2
24 Q00610 Clathrin heavy chain 1 CLTC
25 P26641 Elongation factor 1-gamma EEF1G
26 P32119 Peroxiredoxin-2 PRDX2
27 P19971 Thymidine phosphorylase TYMP
28 P26038 Moesin MSN
29 P40121 Macrophage-capping protein CAPG
30 P35754 Glutaredoxin-1 GLRX
31 P01009 Alpha-1-antitrypsin SERPINA1
32 P01860 Immunoglobulin heavy constant gamma 3 IGHG3
33 P06753 Tropomyosin alpha-3 chain TPM3
34 P68871 Hemoglobin subunit beta HBB
35 P62805 Histone H4 H4C1
36 P30086 Phosphatidylethanolamine-binding protein 1 PEBP1
37 P35579 Myosin-9 MYH9
38 P01023 Alpha-2-macroglobulin A2M
39 Q06830 Peroxiredoxin-1 PRDX1
40 P02042 Hemoglobin subunit delta HBD
41 P07737 Profilin-1 PFN1
42 P80188 Neutrophil gelatinase-associated lipocalin LCN2
43 P02679 Fibrinogen gamma chain FGG
44 P40925 Malate dehydrogenase, cytoplasmic MDH1
45 P08758 Annexin A5 ANXA5
46 P46940 Ras GTPase-activating-like protein IQGAP1 IQGAP1
47 P01833 Polymeric immunoglobulin receptor PIGR
48 P31949 Protein S100-A11 S100A11
49 P04792 Heat shock protein beta-1 HSPB1
50 P07339 Cathepsin D CTSD
51 P01857 Immunoglobulin heavy constant gamma 1 IGHG1
52 P06733 Alpha-enolase ENO1
53 P23284 Peptidyl-prolyl cis-trans isomerase B PPIB
54 P02647 Apolipoprotein A-I APOA1
55 O43707 Alpha-actinin-4 ACTN4
56 P30740 Leukocyte elastase inhibitor SERPINB1
57 Q16610 Extracellular matrix protein 1 ECM1
58 P60709 Actin, cytoplasmic 1 ACTB
59 P15924 Desmoplakin DSP
60 P62937 Peptidyl-prolyl cis-trans isomerase A PPIA
61 P17931 Galectin-3 LGALS3
62 P00491 Purine nucleoside phosphorylase PNP
63 P04080 Cystatin-B CSTB
64 P02788 Lactotransferrin LTF
65 P13639 Elongation factor 2 EEF2
66 P35527 Keratin, type I cytoskeletal 9 KRT9
67 P06396 Gelsolin GSN
68 P59998 Actin-related protein 2/3 complex subunit 4 ARPC4
69 P25311 Zinc-alpha-2-glycoprotein AZGP1
70 P02768 Albumin ALB
71 P61160 Actin-related protein 2 ACTR2
72 P04406 Glyceraldehyde-3-phosphate dehydrogenase GAPDH
73 P60174 Triosephosphate isomerase TPI1
74 P18206 Vinculin VCL
75 P08670 Vimentin VIM
76 P10599 Thioredoxin TXN
77 P11142 Heat shock cognate 71 kDa protein HSPA8
78 P01011 Alpha-1-antichymotrypsin SERPINA3
79 P04075 Fructose-bisphosphate aldolase A ALDOA
80 P04264 Keratin, type II cytoskeletal 1 KRT1
81 P37837 Transaldolase TALDO1
82 P35908 Keratin, type II cytoskeletal 2 epidermal KRT2
83 P02545 Prelamin-A/C LMNA
84 P69905 Hemoglobin subunit alpha HBA1
85 P07900 Heat shock protein HSP 90-alpha HSP90AA1
86 P29401 Transketolase TKT
87 P00558 Phosphoglycerate kinase 1 PGK1
88 P00338 L-lactate dehydrogenase A chain LDHA
89 P01861 Immunoglobulin heavy constant gamma 4 IGHG4
90 P05109 Protein S100-A8 S100A8
91 P04083 Annexin A1 ANXA1
92 P01024 Complement C3 C3
93 P09211 Glutathione S-transferase P GSTP1

Venn diagram and GO annotation

To take a closer look at this comparison, we focused on five body fluids that have the most protein counts, including blood, urine, CSF, SF) and BALF. An interesting discovery is that urine shares large numbers of common proteins with other fluids (Figure 7). A total of 4109, 3212, 2990 and 2950 proteins overlapped between the plasma and the other four body fluids (blood, CSF, SF and BALF, respectively). There are 965 proteins commonly detected in all five body fluids. The functional analysis using the BiNGO tool (183) in Cytoscape (184), reflecting information about cellular localization, molecular function and biological process of these proteins (Figure 8).

Figure 7.

Figure 7.

Venn diagram showing the common proteins among five body fluids (blood, urine, CSF, SF and BALF) that have the most number of proteins in the HBFP.

Figure 8.

Figure 8.

Example of GO annotation based on the 965 proteins common in five body fluids.

Conclusions

The new HBFP database developed in this study represents the first of its kind as a comprehensive reference resource of HBFP. All data are available through an open-access user-friendly Web platform. All protein entries were manually curated, which can be easily traced back to the original literature. Users can query and download proteins of interest to verify discovery in their own study or conduct an in silico analysis on human secretomes. We currently schedule a regular update every 6 months. The future plan is to include computationally identified proteins using statistical and machine learning approaches (185–191). In the past decade, many computational studies have revealed unique strengths in overcoming challenges in profiling-based proteomics research in terms of discovering new protein bioavailability and functions. Those computationally predicted proteins can serve as a secondary resource for biomarker discovery. In summary, by providing a wealth of information and functional analysis, we believe the HBFP database can be an excellent tool for the research community to explore human proteome in various body fluids.

Funding

National Natural Science Foundation of China (no. 62072212); Development Project of Jilin Province of China (nos 20200401083GX, 2020LY500L06 and 2020C003); Guangdong Key Project for Applied Fundamental Research (grant 2018KZDXM076); Jilin Province Key Laboratory of Big Data Intelligent Computing (no. 20180622002JC).

Contributor Information

Dan Shao, Department of Computer Science and Engineering, University of Nebraska-Lincoln, 122E Avery Hall, 1144 T St., Lincoln, NE 68588, USA; Key Laboratory of Symbol Computation and Knowledge Engineering of Ministry of Education, College of Computer Science and Technology, Jilin University, 2699 Qianjin Street, Changchun 130012, China; Department of Computer Science and Technology, Changchun University, 6543 Weixing Road, Changchun 130022, China.

Lan Huang, Key Laboratory of Symbol Computation and Knowledge Engineering of Ministry of Education, College of Computer Science and Technology, Jilin University, 2699 Qianjin Street, Changchun 130012, China.

Yan Wang, Key Laboratory of Symbol Computation and Knowledge Engineering of Ministry of Education, College of Computer Science and Technology, Jilin University, 2699 Qianjin Street, Changchun 130012, China.

Xueteng Cui, Department of Computer Science and Technology, Changchun University, 6543 Weixing Road, Changchun 130022, China.

Yufei Li, Department of Computer Science and Technology, Changchun University, 6543 Weixing Road, Changchun 130022, China.

Yao Wang, Key Laboratory of Symbol Computation and Knowledge Engineering of Ministry of Education, College of Computer Science and Technology, Jilin University, 2699 Qianjin Street, Changchun 130012, China.

Qin Ma, Department of Biomedical Informatics, College of Medicine, The Ohio State University, 310G Lincoln tower, 1800 cannon drive, Columbus, OH 43210, USA.

Wei Du, Key Laboratory of Symbol Computation and Knowledge Engineering of Ministry of Education, College of Computer Science and Technology, Jilin University, 2699 Qianjin Street, Changchun 130012, China.

Juan Cui, Department of Computer Science and Engineering, University of Nebraska-Lincoln, 122E Avery Hall, 1144 T St., Lincoln, NE 68588, USA.

Conflict of interest

The authors declare that they have no competing interests.

References

  • 1.Anderson N.L. (2010) The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin. Chem., 56, 177–185. [DOI] [PubMed] [Google Scholar]
  • 2.Lathrop J., Anderson N., Anderson N.. et al. (2003) Therapeutic potential of the plasma proteome. Curr. Opin. Mol. Ther., 5, 250–257. [PubMed] [Google Scholar]
  • 3.Hu S., Loo J. and Wong D. (2006) Human body fluid proteome analysis. Proteomics, 6, 6326–6353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Omenn G.S., States D.J., Adamski M.. et al. (2005) Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics, 5, 3226–3245. [DOI] [PubMed] [Google Scholar]
  • 5.Nanjappa V., Thomas J.K., Marimuthu A.. et al. (2014) Plasma Proteome Database as a resource for proteomics research: 2014 update. Nucleic Acids Res., 42, D959–D965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Vizcaíno J., Côté R., Reisinger F.. et al. (2010) The Proteomics Identifications database: 2010 update. Nucleic Acids Res., 38, D736–D742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Schwenk J.M., Omenn G.S., Sun Z.. et al. (2017) The human plasma proteome draft of 2017: building on the Human Plasma PeptideAtlas from mass spectrometry and complementary assays. J. Proteome Res., 16, 4299–4310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Keerthikumar S., Chisanga D., Ariyaratne D.. et al. (2016) ExoCarta: a web-based compendium of exosomal cargo. J. Mol. Biol., 428, 688–692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Deutsch E.W., Overall C.M., Eyk J.V.. et al. (2016) Human Proteome Project mass spectrometry data interpretation guidelines 2.1. J. Proteome Res., 15, 3961–3970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Huang L., Shao D., Wang Y.. et al. (2021) Human body-fluid proteome: quantitative profiling and computational prediction. Brief. Bioinformatics, 22, 315–333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.UniProt Consortium (2015) UniProt: a hub for protein information. Nucleic Acids Res., 43, D204–D212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Mudunuri U., Che A., Yi M.. et al. (2009) bioDBnet: the biological database network. Bioinformatics, 25, 555–556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lydie L., Ghislaine A.P., Aurore B.. et al. (2012) neXtProt: a knowledge platform for human proteins. Nucleic Acids Res., 40, D76–D83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wang M., Wang J., Carver J.. et al. (2018) Assembling the community-scale discoverable human proteome. Cell Syst., 7, 412–421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Minoru K., Michihiro A., Susumu G.. et al. (2008) KEGG for linking genomes to life and the environment. Nucleic Acids Res., 36, D480–D484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Carbon S., Ireland A., Mungall C.J.. et al. (2009) AmiGO: online access to ontology and annotation data. Bioinformatics, 25, 288–289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Mathieu S., Alain G., Daniel T.. et al. (2017) The neXtProt peptide uniqueness checker: a tool for the proteomics community. Bioinformatics, 33, 3471–3472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zhao Y., Chang C., Qin P.. et al. (2016) Mining the human plasma proteome with three-dimensional strategies by high-resolution Quadrupole Orbitrap Mass Spectrometry. Anal. Chim. Acta, 904, 65–75. [DOI] [PubMed] [Google Scholar]
  • 19.Zhao M., Yang Y., Guo Z.. et al. (2018) A comparative proteomics analysis of five body fluids: plasma, urine, cerebrospinal fluid, amniotic fluid and saliva. Proteomics Clin. Appl., 12, e1800008. [DOI] [PubMed] [Google Scholar]
  • 20.Yan W., Apweiler R., Balgley B.M.. et al. (2010) Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin. Appl., 3, 116–134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Moreno S.O., Cominetti O., Galindo A.N.. et al. (2017) The differential plasma proteome of obese and overweight individuals undergoing a nutritional weight loss and maintenance intervention. Proteomics Clin. Appl., 12, 1600150. [DOI] [PubMed] [Google Scholar]
  • 22.Li L., Xu Y. and Yu C.X. (2012) Proteomic analysis of serum of women with elevated Ca-125 to differentiate malignant from benign ovarian tumors. Asian Pac. J. Cancer Prev., 13, 3265–3270. [DOI] [PubMed] [Google Scholar]
  • 23.Chen L.Z., Gu H., Li J.. et al. (2016) Comprehensive maternal serum proteomics identifies the cytoskeletal proteins as non-invasive biomarkers in prenatal diagnosis of congenital heart defects. Sci. Rep., 6, 19248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Acosta-Martin A.E., Panchaud A., Chwastyniak M.. et al. (2011) Quantitative mass spectrometry analysis using PAcIFIC for the identification of plasma diagnostic biomarkers for abdominal aortic aneurysm. PLoS One, 6, e28698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Pietzner M., Engelmann B., Kacprowski T.. et al. (2017) Plasma proteome and metabolome characterization of an experimental human thyrotoxicosis model. BMC Med., 15, 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Boichenko A.P., Govorukhina N., Klip H.G.. et al. (2014) A panel of regulated proteins in serum from patients with cervical intraepithelial neoplasia and cervical cancer. J. Proteome Res., 13, 4995–5007. [DOI] [PubMed] [Google Scholar]
  • 27.Geyer P.E., Kulak N.A., Pichler G.. et al. (2016) Plasma proteome profiling to assess human health and disease. Cell Syst., 2, 185–195. [DOI] [PubMed] [Google Scholar]
  • 28.Geyer P.E., Wewer Albrechtsen N.J., Tyanova S.. et al. (2016) Proteomics reveals the effects of sustained weight loss on the human plasma proteome. Mol. Syst. Biol., 12, 901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Yadav A.K., Bhardwaj G., Basak T.. et al. (2011) A systematic analysis of eluted fraction of plasma post immunoaffinity depletion: implications in biomarker discovery. PLoS One, 6, e24442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Liu Z., Fan S., Liu H.. et al. (2016) Enhanced detection of low-abundance human plasma proteins by integrating polyethylene glycol fractionation and immunoaffinity depletion. PLoS One, 11, e0166306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Limonier F., Steendam K.V., Waeterloos G.. et al. (2016) An application of mass spectrometry for quality control of biologicals: highly sensitive profiling of plasma residuals in human plasma-derived immunoglobulin. J. Proteomics, 152, 312–320. [DOI] [PubMed] [Google Scholar]
  • 32.Bjelosevic S., Pascovici D., Ping H.. et al. (2017) Quantitative age-specific variability of plasma proteins in healthy neonates, children and adults. Mol. Cell Proteomics, 16, 924–935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Farrah T., Deutsch E.W., Omenn G.S.. et al. (2011) A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol. Cell. Proteomics, 152, 312–320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Gautam P., Nair S.C., Ramamoorthy K.. et al. (2013) Analysis of human blood plasma proteome from ten healthy volunteers from Indian population. PLoS One, 8, e72584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Cheon D.H., Nam E.J., Park K.H.. et al. (2016) Comprehensive analysis of low-molecular-weight human plasma proteome using top-down mass spectrometry. J. Proteome Res., 15, 229–244. [DOI] [PubMed] [Google Scholar]
  • 36.Zhou M., Prieto D.A., Lucas D.A.. et al. (2006) Identification of the SELDI ProteinChip human serum retentate by microcapillary liquid chromatography-tandem mass spectrometry. J. Proteome Res., 5, 2207–2216. [DOI] [PubMed] [Google Scholar]
  • 37.Zeng Z., Hincapie M., Pitteri S.J.. et al. (2011) A proteomics platform combining depletion, multi-lectin affinity chromatography(M-LAC), and isoelectric focusing to study the breast cancer proteome. Anal. Chem., 83, 4845–4854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Pan S., Chen R., Crispin D.A.. et al. (2011) Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. J. Proteome Res., 10, 2359–2376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Surinova S., Choi M., Tao S.. et al. (2015) Prediction of colorectal cancer diagnosis based on circulating plasma proteins. EMBO Mol. Med., 7, 1166–1178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Harel M., Oren-Giladi P., Kaidar-Person O.. et al. (2015) Proteomics of microparticles with SILAC Quantification (PROMIS-Quan): a novel proteomic method for plasma biomarker quantification. Mol. Cell. Proteomics, 14, 1127–1136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Carvalho A.S., Cuco C.M., Lavareda C.. et al. (2017) Bronchoalveolar lavage proteomics in patients with suspected lung cancer. Sci. Rep., 7, 42190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Zhou B., Zhou Z., Chen Y.. et al. (2019) Plasma proteomics-based identification of novel biomarkers in early gastric cancer. Clin. Biochem., 76, 5–10. [DOI] [PubMed] [Google Scholar]
  • 43.Du Z., Liu X., Wei X.. et al. (2020) Quantitative proteomics identifies a plasma multi-protein model for detection of hepatocellular carcinoma. Sci. Rep., 10, 15552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Park J., Kim H., Kim S.Y.. et al. (2020) In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients. Sci. Rep., 10, 22418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Garay-Baquero D.J., White C.H., Walker N.F.. et al. (2020) Comprehensive plasma proteomic profiling reveals biomarkers for active tuberculosis. JCI Insight, 5, e137427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Kumar V., Ray S., Ghantasala S.. et al. (2020) An integrated quantitative proteomics workflow for cancer biomarker discovery and validation in plasma. Front. Oncol., 10, 543997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Geyer P.E., Arend F.M., Doll S.. et al. (2021) High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion. EMBO Mol. Med., 13, e14167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Messner C.B., Demichev V., Wendisch D.. et al. (2020) Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection. Cell Syst., 11, 11–24.e4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Ming C., Yi L., Hla B.. et al. (2020) Quantitative proteomics and reverse engineer analysis identified plasma exosome derived protein markers related to osteoporosis. J. Proteomics, 228, 103940. [DOI] [PubMed] [Google Scholar]
  • 50.Yang T., Fu Z., Zhang Y.. et al. (2020) Serum proteomics analysis of candidate predictive biomarker panel for the diagnosis of trastuzumab-based therapy resistant breast cancer. Biomed. Pharmacother., 129, 110465. [DOI] [PubMed] [Google Scholar]
  • 51.Dey K.K., Wang H., Niu M.. et al. (2019) Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer’s disease. Clin. Proteomics, 16, 16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Smolarz M., Pietrowska M., Matysiak N.. et al. (2019) Proteome profiling of exosomes purified from a small amount of human serum: the problem of co-purified serum components. Proteomes, 7, 18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Lin L., Zheng J., Yu Q.. et al. (2017) High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis. J. Proteomics, 174, 9–16. [DOI] [PubMed] [Google Scholar]
  • 54.Ren J., Zhao G., Sun X.. et al. (2017) Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis. Psychoneuroendocrinology, 86, 17–24. [DOI] [PubMed] [Google Scholar]
  • 55.Liu C.W., Bramer L., Webb-Robertson B.J.. et al. (2017) Temporal expression profiling of plasma proteins reveals oxidative stress in early stages of Type 1 diabetes progression. J. Proteomics, 172, 100–110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Rao P.V., Reddy A.P., Lu X.. et al. (2009) Proteomic identification of salivary biomarkers of type-2 diabetes. J. Proteome Res., 8, 239–245. [DOI] [PubMed] [Google Scholar]
  • 57.Guo T., Rudnick P.A., Wang W.J.. et al. (2006) Characterization of the human salivary proteome by capillary isoelectric focusing/nanoreversed-phase liquid chromatography coupled with ESI-tandem MS. J. Proteome Res., 5, 1469–1478. [DOI] [PubMed] [Google Scholar]
  • 58.Wilmarth P.A., Riviere M.A., Rustvold D.L.. et al. (2004) Two-dimensional liquid chromatography study of the human whole saliva proteome. J. Proteome Res., 3, 1017–1023. [DOI] [PubMed] [Google Scholar]
  • 59.Gonzalezbegne M., Lu B.W., Liao L.J.. et al. (2011) Characterization of the human submandibular/sublingual saliva glycoproteome using lectin affinity chromatography coupled to Multidimensional Protein Identification Technology. J. Proteome Res., 10, 5031–5046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Sivadasan P., Gupta M.K., Sathe G.J.. et al. (2015) Data from human salivary proteome – a resource of potential biomarkers for oral cancer. J. Proteomics, 4, 374–378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Cho H.R., Kim H.S., Park J.S.. et al. (2017) Construction and characterization of the Korean whole saliva proteome to determine ethnic differences in human saliva proteome. PLoS One, 12, e0181765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Winck F.V., Ribeiro A.C.P., Domingues R.R.. et al. (2015) Insights into immune responses in oral cancer through proteomic analysis of saliva and salivary extracellular vesicles. Sci. Rep., 5, 16305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Aboodi G.M., Sima C., Moffa E.B.. et al. (2016) Salivary cytoprotective proteins in inflammation and resolution during experimental gingivitis—a pilot study. Front. Cell. Infect. Microbiol., 5, 92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Xie H., Rhodus N.L., Griffin R.J.. et al. (2005) A catalogue of human saliva proteins identified by free flow electrophoresis-based peptide separation and tandem mass spectrometry. Mol. Cell. Proteomics, 4, 1826–1830. [DOI] [PubMed] [Google Scholar]
  • 65.Bandhakavi S., Stone M.D., Onsongo G.. et al. (2009) A dynamic range compression and three-dimensional peptide fractionation analysis platform expands proteome coverage and the diagnostic potential of whole saliva. J. Proteome Res., 8, 5590–5600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.De Jong E.P., Xie H.W., Onsongo G.. et al. (2010) Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions. PLoS One, 5, e11148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Franco-Martínez L., Hernández J.M.G., Horvati A.. et al. (2019) Differences on salivary proteome at rest and in response to an acute exercise in men and women: a pilot study. J. Proteomics, 214, 103629. [DOI] [PubMed] [Google Scholar]
  • 68.Contini C., Olianas A., Serrao S.. et al. (2021) Top-down proteomics of human saliva highlights anti-inflammatory, antioxidant, and antimicrobial defense responses in alzheimer disease. Front. Neurosci., 15, 668852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Sembler-Mller M.L., Belstrm D., Locht H.. et al. (2020) Proteomics of saliva, plasma, and salivary gland tissue in Sjögren’s syndrome and non-Sjögren patients identify novel biomarker candidates. J. Proteomics, 225, 103877. [DOI] [PubMed] [Google Scholar]
  • 70.Xiao X., Liu Y., Guo Z.. et al. (2017) Comparative proteomic analysis of the influence of gender and acid stimulation on normal human saliva using LC/MS/MS. Proteomics Clin. Appl., 11, 1600142. [DOI] [PubMed] [Google Scholar]
  • 71.Sun Y., Huo C., Qiao Z.. et al. (2018) Comparative proteomic analysis of exosomes and microvesicles in human saliva for lung cancer. J. Proteome Res., 17, 1101–1107. [DOI] [PubMed] [Google Scholar]
  • 72.Wu C.C., Chu H.W., Hsu C.W.. et al. (2015) Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma. Proteomics, 15, 3394–3404. [DOI] [PubMed] [Google Scholar]
  • 73.Suresh A. (2015) Human salivary proteome — a resource of potential biomarkers for oral cancer. J. Proteomics, 127, 89–95. [DOI] [PubMed] [Google Scholar]
  • 74.Cecchettini A., Finamore F., Ucciferri N.. et al. (2019) Phenotyping multiple subsets in Sjögren’s syndrome: a salivary proteomic SWATH-MS approach towards precision medicine. Clin. Proteomics, 16, 26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Jehmlich N., Dinh K., Gesell-Salazar M.. et al. (2013) Quantitative analysis of the intra- and inter-subject variability of the whole salivary proteome. J. Periodont. Res., 48, 392–403. [DOI] [PubMed] [Google Scholar]
  • 76.Castagna A., Cecconi D., Sennels L.. et al. (2005) Exploring the hidden human urinary proteome via ligand library beads. J. Proteome Res., 4, 1917–1930. [DOI] [PubMed] [Google Scholar]
  • 77.Alamgir K. and Packer N.H. (2006) Simple urinary sample preparation for proteomic analysis. J. Proteome Res., 5, 2824–2838. [DOI] [PubMed] [Google Scholar]
  • 78.Li Q.R., Fan K.X., Li R.X.. et al. (2010) A comprehensive and non-prefractionation on the protein level approach for the human urinary proteome: touching phosphorylation in urine. Rapid Commun. Mass Spectrom. RCM, 24, 823–832. [DOI] [PubMed] [Google Scholar]
  • 79.Guo Z., Wang Z., Lu C.. et al. (2018) Analysis of the differential urinary protein profile in IgA nephropathy patients of Uygur ethnicity. BMC Nephrol., 19, 358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Hogan M.C., Johnson K.L., Zenka R.M.. et al. (2014) Subfractionation, characterization, and in-depth proteomic analysis of glomerular membrane vesicles in human urine. Kidney Int., 85, 1225–1237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Nielsen H.H., Beck H.C., Kristensen L.P.. et al. (2015) The urine proteome profile is different in neuromyelitis optica compared to multiple sclerosis: a clinical proteome study. PLoS One, 10, e0139659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Lin L., Yu Q., Zheng J.X.. et al. (2018) Fast quantitative urinary proteomic profiling workflow for biomarker discovery in kidney cancer. Clin. Proteomics, 15, 42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Zhao M.D., Li M.L., Yang Y.H.. et al. (2017) A comprehensive analysis and annotation of human normal urinary proteome. Sci. Rep., 7, 3024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Onile O.S., Calder B., Soares N.C.. et al. (2017) Quantitative label-free proteomic analysis of human urine to identify novel candidate protein biomarkers for schistosomiasis. PLoS Negl. Trop. Dis., 11, e0006045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Simona P., Yunee K., Simona F.. et al. (2012) Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine. J. Proteome Res., 11, 2386–2396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Adachi J., Kumar C., Zhang Y.L.. et al. (2006) The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol., 7, R80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Liu X.J., Shao C., Wei L.L.. et al. (2012) An individual urinary proteome analysis in normal human beings to define the minimal sample number to represent the normal urinary proteome. Proteome Sci., 10, 70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Zheng J.H., Liu L.G., Wang J.. et al. (2013) Urinary proteomic and non-prefractionation quantitative phosphoproteomic analysis during pregnancy and non-pregnancy. BMC Genomics, 14, 777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Marimuthu A., O’Meally R.N., Chaerkady R.. et al. (2011) A comprehensive map of the human urinary proteome. J. Proteome Res., 10, 2734–2743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Guo Z.G., Zhang Y., Zou L.L.. et al. (2015) A proteomic analysis of individual and gender variations in normal human urine and cerebrospinal fluid using iTRAQ quantification. PLoS One, 10, e0133270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Prikryl P., Satrapova V., Frydlova J.. et al. (2020) Mass spectrometry-based proteomic exploration of the small urinary extracellular vesicles in ANCA-associated vasculitis in comparison with total urine. J. Proteomics, 233, 104067. [DOI] [PubMed] [Google Scholar]
  • 92.Swensen A.C., He J., Fang A.C.. et al. (2021) A comprehensive urine proteome database generated from patients with various renal conditions and prostate cancer. Front. Med., 8, 548212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Li Y., Wang Y., Liu H.. et al. (2021) Urine proteome of COVID-19 patients. URINE, 2, 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Chen R., Yi Y., Xiao W.. et al. (2021) Label-free liquid chromatography–mass spectrometry proteomic analysis of urinary identification in diabetic vascular dementia in a han chinese population. Front. Aging Neurosci., 13, 619945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Huo S., Wang H.X., Yan M.X.. et al. (2021) Urinary proteomic characteristics of hyperuricemia and their possible links with the occurrence of its concomitant diseases. ACS Omega, 6, 9500–9508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Ahn H.S., Kim J.H., Jeong H.. et al. (2020) Differential urinary proteome analysis for predicting prognosis in type 2 diabetes patients with and without renal dysfunction. Int. J. Mol. Sci., 21, 4236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Chen C.J., Chou C.Y., Shu K.H.. et al. (2021) Discovery of novel protein biomarkers in urine for diagnosis of urothelial cancer using iTRAQ proteomics. J. Proteome Res., 20, 2953–2963. [DOI] [PubMed] [Google Scholar]
  • 98.Pan S., Wang Y., Quinn J.F.. et al. (2006) Identification of glycoproteins in human cerebrospinal fluid with a complementary proteomic approach. J. Proteome Res., 5, 2769–2779. [DOI] [PubMed] [Google Scholar]
  • 99.Guldbrandsen A., Vethe H., Farag Y.. et al. (2014) In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR). Mol. Cell. Proteomics Mcp, 13, 3152–3163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Mouton-Barbosa E., Roux-Dalvai F., Bouyssié D.. et al. (2010) In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification. Mol. Cell. Proteomics, 9, 1006–1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Schutzer S.E., Liu T., Natelson B.H.. et al. (2010) Establishing the proteome of normal human cerebrospinal fluid. PLoS One, 5, e10980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Borg J., Campos A., Diema C.. et al. (2011) Spectral counting assessment of protein dynamic range in cerebrospinal fluid following depletion with plasma-designed immunoaffinity columns. Clin. Proteomics, 8, 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Hu Z.Y., Zhang H.Y., Zhang Y.. et al. (2014) Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles. Colloids Surf B Biointerfaces, 121, 354–361. [DOI] [PubMed] [Google Scholar]
  • 104.Schutzer S.E., Angel T.E., Liu T.. et al. (2011) Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS One, 6, e17287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Pan S., Zhu D., Quinn J.F.. et al. (2007) A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. Proteomics, 7, 469–473. [DOI] [PubMed] [Google Scholar]
  • 106.Begcevic I., Brinc D., Drabovich A.P.. et al. (2016) Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas. Clin. Proteomics, 13, 11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Charlotte M., Lydie L., Antonio N.G.. et al. (2018) Deep dive in the proteome of human cerebrospinal fluid: a valuable data resource for biomarker discovery and missing protein identification. J. Proteome Res., 17, 4113–4126. [DOI] [PubMed] [Google Scholar]
  • 108.Yang C., Guo W.B., Zhang W.S.. et al. (2017) Comprehensive proteomics analysis of exosomes derived from human seminal plasma. Andrology, 5, 1007–1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Ashok A., Ahmet A., Luna S.. et al. (2015) Comparative proteomic network signatures in seminal plasma of infertile men as a function of reactive oxygen species. Clin. Proteomics, 12, 23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Pilch B. and Mann M. (2006) Large-scale and high-confidence proteomic analysis of human seminal plasma. Genome Biol., 7, R40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Wang G., Guo Y., Tao Z.. et al. (2013) In-depth proteomic analysis of the human sperm reveals complex protein compositions. J. Proteomics, 79, 114–122. [DOI] [PubMed] [Google Scholar]
  • 112.Zhang X.G., Vos H.R., Tao W.. et al. (2020) Proteomic profiling of two distinct populations of extracellular vesicles isolated from human seminal plasma. Int. J. Mol. Sci., 21, 7957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Lee J., Lee J.E., Choi J.W.. et al. (2020) Proteomic analysis of amniotic fluid proteins for predicting the outcome of emergency cerclage in women with cervical insufficiency. Reprod. Sci., 27, 1318–1329. [DOI] [PubMed] [Google Scholar]
  • 114.Cho C.K., Smith C.R. and Diamandis E.P. (2010) Amniotic fluid proteome analysis from Down syndrome pregnancies for biomarker discovery. J. Proteome Res., 9, 3574–3582. [DOI] [PubMed] [Google Scholar]
  • 115.Liu X., Song Y.J., Guo Z.G.. et al. (2019) A comprehensive profile and inter-individual variations analysis of the human normal amniotic fluid proteome. J. Proteomics, 192, 1–9. [DOI] [PubMed] [Google Scholar]
  • 116.Jeon H.S., Lee S.M., Jung Y.M.. et al. (2020) Proteomic biomarkers in mid-trimester amniotic fluid associated with adverse pregnancy outcomes in patients with systemic lupus erythematosus. PLoS One, 15, e0235838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Hong S., Ji E.L., Yu M.K.. et al. (2020) Identifying potential biomarkers related to pre-term delivery by proteomic analysis of amniotic fluid. Sci. Rep., 10, 19648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Zhou L., Zhao S.Z., Koh S.K.. et al. (2012) In-depth analysis of the human tear proteome. J. Proteomics, 75, 3877–3885. [DOI] [PubMed] [Google Scholar]
  • 119.Liu Q., Liu J., Ren C.. et al. (2017) Proteomic analysis of tears following acupuncture treatment for menopausal dry eye disease by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry. Int. J. Nanomed., 12, 1663–1671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Huang Z., Du C.X. and Pan X.D. (2018) The use of in-strip digestion for fast proteomic analysis on tear fluid from dry eye patients. PLoS One, 13, e0200702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Soria J., Acera A., Merayo-Lloves J.. et al. (2017) Tear proteome analysis in ocular surface diseases using label-free LC-MS/MS and multiplexed-microarray biomarker validation. Rep, 7, 17478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Nttinen J., Mkinen P., Aapola U.. et al. (2020) Early changes in tear film protein profiles after femtosecond LASIK surgery. Clin. Proteomics, 17, 36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Csősz É., Boross P., Csutak A.. et al. (2012) Quantitative analysis of proteins in the tear fluid of patients with diabetic retinopathy. J. Proteomics, 75, 2196–2204. [DOI] [PubMed] [Google Scholar]
  • 124.Chen X.L., Rao J., Zheng Z.. et al. (2019) Integrated tear proteome and metabolome reveal panels of inflammatory-related molecules via key regulatory pathways in dry eye syndrome. J. Proteome Res., 18, 2321–2330. [DOI] [PubMed] [Google Scholar]
  • 125.Tong L., Zhou X.Y., Jylha A.. et al. (2015) Quantitation of 47 human tear proteins using high resolution multiple reaction monitoring (HR-MRM) based-mass spectrometry. J. Proteomics, 115, 36–48. [DOI] [PubMed] [Google Scholar]
  • 126.Boerger M., Funke S., Leha A.. et al. (2019) Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson’s disease – a pilot study. Parkinsonism Relat. Disord., 63, 3–9. [DOI] [PubMed] [Google Scholar]
  • 127.Cheung J.K.W., Bian J.F., Sze Y.H.. et al. (2021) Human tear proteome dataset in response to daily wear of water gradient contact lens using SWATH-MS approach. Data Brief, 36, 107120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Dor M., Eperon S., Lalive P.H.. et al. (2018) Investigation of the global protein content from healthy human tears. Exp. Eye Res., 179, 64–74. [DOI] [PubMed] [Google Scholar]
  • 129.Almatroodi S.A., Mcdonald C.F., Collins A.L.. et al. (2015) Quantitative proteomics of bronchoalveolar lavage fluid in lung adenocarcinoma. Cancer Genomics Proteomics, 12, 39–48. [PubMed] [Google Scholar]
  • 130.Sim S.Y., Choi Y.R., Lee J.H.. et al. (2019) In-depth proteomic analysis of human bronchoalveolar lavage fluid toward the biomarker discovery for lung cancers. Proteomics. Clin. Appl., 13, e1900028. [DOI] [PubMed] [Google Scholar]
  • 131.Foster M.W., Thompson J.W., Que L.G.. et al. (2013) Proteomic analysis of human bronchoalveolar lavage fluid after subsgemental exposure. J. Proteome Res., 12, 2194–2205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Ortea I., Rodríguez-Ariza A., Chicano-Gálvez E.. et al. (2016) Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction. J. Proteomics, 138, 106–114. [DOI] [PubMed] [Google Scholar]
  • 133.Foster M.W., Morrison L.D., Todd J.L.. et al. (2015) Quantitative proteomics of bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. J. Proteome Res., 14, 1238–1249. [DOI] [PubMed] [Google Scholar]
  • 134.Yang M., Cong M., Peng X.. et al. (2016) Quantitative proteomic analysis of milk fat globule membrane (MFGM) proteins in human and bovine colostrum and mature milk samples through iTRAQ labeling. Food Funct., 7, 2438–2450. [DOI] [PubMed] [Google Scholar]
  • 135.Liao Y., Alvarado R., Phinney B.. et al. (2011) Proteomic characterization of human milk whey proteins during a twelve-month lactation period. J. Proteome Res., 10, 1746–1754. [DOI] [PubMed] [Google Scholar]
  • 136.Beck K.L., Weber D., Phinney B.S.. et al. (2015) Comparative proteomics of human and macaque milk reveals species-specific nutrition during postnatal development. J. Proteome Res., 14, 2143–2157. [DOI] [PubMed] [Google Scholar]
  • 137.Liao Y.L., Alvarado R., Phinney B.. et al. (2011) Proteomic characterization of specific minor proteins in the human milk casein fraction. J. Proteome Res., 10, 5409–5415. [DOI] [PubMed] [Google Scholar]
  • 138.Zhang Q., Cundiff J.K., Maria S.D.. et al. (2013) Quantitative analysis of the human milk whey proteome reveals developing milk and mammary-gland functions across the first year of lactation. Proteomes, 1, 128–158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139.Molinari C.E., Casadio Y.S., Hartmann B.T.. et al. (2012) Proteome mapping of human skim milk proteins in term and preterm milk. J. Proteome Res., 11, 1696–1714. [DOI] [PubMed] [Google Scholar]
  • 140.Kim B.J. and Dallas D.C. (2021) Systematic examination of protein extraction, proteolytic glycopeptide enrichment and MS/MS fragmentation techniques for site-specific profiling of human milk N-glycoproteins. Talanta, 224, 121811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.Dallas D.C., Guerrero A., Khaldi N.. et al. (2013) Extensive in vivo human milk peptidomics reveals specific proteolysis yielding protective antimicrobial peptides. J. Proteome Res., 12, 2295–2304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142.Picariello G., Ferranti P., Mamone G.. et al. (2012) Gel-free shotgun proteomic analysis of human milk. J. Chromatogr. A, 1227, 219–233. [DOI] [PubMed] [Google Scholar]
  • 143.Liao Y., Alvarado R., Phinney B.. et al. (2011) Proteomic characterization of human milk fat globule membrane proteins during a 12 month lactation period. J. Proteome Res., 10, 3530–3541. [DOI] [PubMed] [Google Scholar]
  • 144.Dayon L., Macron C., Lahrichi S.. et al. (2021) Proteomics of human milk: definition of a discovery workflow for clinical research studies. J. Proteome Res., 20, 2283–2290. [DOI] [PubMed] [Google Scholar]
  • 145.Goonatilleke E., Huang J., Xu G.. et al. (2019) Human milk proteins and their glycosylation exhibit quantitative dynamic variations during lactation. J. Nutr., 149, 1317–1325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146.Zhou Y.H., Le Z., Yu Z.B.. et al. (2019) Peptidomic analysis reveals multiple protection of human breast milk on infants during different stages. J. Cell. Physiol., 234, 15510–15526. [DOI] [PubMed] [Google Scholar]
  • 147.Gan J., Robinson R.C., Wang J.. et al. (2018) Peptidomic profiling of human milk with LC-MS/MS reveals pH-specific proteolysis of milk proteins. Food Chem., 274, 766–774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Balakrishnan L., Nirujogi R.S., Ahmad S.. et al. (2014) Proteomic analysis of human osteoarthritis synovial fluid. Clin. Proteomics, 11, 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 149.Balakrishnan L., Bhattacharjee M., Ahmad S.. et al. (2014) Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients. Clin. Proteomics, 11, 1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 150.Rydholm U. (2016) Synovial fluid proteome in rheumatoid arthritis. Acta Orthop., 77, 1–11. [Google Scholar]
  • 151.Mahendran S.M., Keystone E.C., Krawetz R.J.. et al. (2019) Elucidating the endogenous synovial fluid proteome and peptidome of inflammatory arthritis using label-free mass spectrometry. Clin. Proteomics, 16, 23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 152.Birkelund S., Bennike T.B., Kastaniegaard K.. et al. (2020) Proteomic analysis of synovial fluid from rheumatic arthritis and spondyloarthritis patients. Clin. Proteomics, 17, 29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153.Foers A.D., Dagley L.F., Chatfield S.. et al. (2020) Proteomic analysis of extracellular vesicles reveals an immunogenic cargo in rheumatoid arthritis synovial fluid. Clin. Transl. Immunol., 9, e1185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 154.Lee J.H., Jung J.H., Kim J.. et al. (2020) Proteomic analysis of human synovial fluid reveals potential diagnostic biomarkers for ankylosing spondylitis. Clin. Proteomics, 17, 20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155.Brunoro G.V., Carvalho P.C., Ferreira A.T.. et al. (2015) Proteomic profiling of nipple aspirate fluid (NAF): exploring the complementarity of different peptide fractionation strategies. J. Proteomics, 117, 86–94. [DOI] [PubMed] [Google Scholar]
  • 156.Alexander H., Stegner A.L., Wagner-Mann C.. et al. (2004) Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin. Cancer Res., 10, 7500–7510. [DOI] [PubMed] [Google Scholar]
  • 157.Kurono S., Kaneko Y., Matsuura N.. et al. (2016) Identification of potential breast cancer markers in nipple discharge by protein profile analysis using two-dimensional nano-liquid chromatography/nanoelectrospray ionization-mass spectrometry. Proteomics Clin. Appl., 10, 605–613. [DOI] [PubMed] [Google Scholar]
  • 158.Shaheed S.U., Tait C., Kyriacou K.. et al. (2017) Nipple aspirate fluid - a liquid biopsy for diagnosing breast health. Proteomics Clin. Appl., 11, 1700015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 159.Pavlou M.P., Kulasingam V., Sauter E.R.. et al. (2010) Nipple aspirate fluid proteome of healthy females and patients with breast cancer. Clin. Chem., 56, 848–855. [DOI] [PubMed] [Google Scholar]
  • 160.Kim Y.E., Kim K., Han B.O.. et al. (2021) Quantitative proteomic profiling of Cervicovaginal fluid from pregnant women with term and preterm birth. Proteome Sci., 19, 3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161.Muytjens C., Yu Y. and Diamandis E.P. (2017) Discovery of antimicrobial peptides in cervical-vaginal fluid from healthy nonpregnant women via an integrated proteome and peptidome analysis. Proteomics, 17, 1600461. [DOI] [PubMed] [Google Scholar]
  • 162.Federi C.C., Valerie W., Silvia T.. et al. (2013) Proteome profiles of vaginal fluids from women affected by bacterial vaginosis and healthy controls: outcomes of rifaximin treatment. J. Antimicrob. Chemother., 68, 2648–2659. [DOI] [PubMed] [Google Scholar]
  • 163.Starodubtseva N.L., Brzhozovzkiy A.G., Bugrova A.E.. et al. (2019) Label-free cervicovaginal fluid proteome profiling reflects the cervix neoplastic transformation. J. Mass Spectrom., 54, 693–703. [DOI] [PubMed] [Google Scholar]
  • 164.Hosako M., Muto T., Nakamura Y.. et al. (2012) Proteomic study of malignant pleural mesothelioma by laser microdissection and two-dimensional difference gel electrophoresis identified cathepsin D as a novel candidate for a differential diagnosis biomarker. J. Proteomics, 75, 833–844. [DOI] [PubMed] [Google Scholar]
  • 165.Mundt F., Johansson H.J., Forshed J.. et al. (2013) Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma. Mol. Cell. Proteomics, 13, 701–715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 166.Park J.O., Choi D.Y., Choi D.S.. et al. (2013) Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions. Proteomics, 13, 2125–2134. [DOI] [PubMed] [Google Scholar]
  • 167.Burg D., Schofield J.P.R., Brandsma J.. et al. (2018) Large-scale label-free quantitative mapping of the sputum proteome. J. Proteome Res., 17, 2072–2091. [DOI] [PubMed] [Google Scholar]
  • 168.Hailemariam M., Yu Y.B., Singh H.. et al. (2020) Protein and microbial biomarkers in sputum discern acute and latent tuberculosis in investigation of pastoral Ethiopian cohort. Front. Cell. Infect. Microbiol., 11, 595554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 169.Gray R.D., Macgregor G., Noble D.. et al. (2008) Sputum proteomics in inflammatory and suppurative respiratory diseases. Am. J. Respir. Crit. Care Med., 178, 444–452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 170.Muccilli V., Saletti R., Cunsolo V.. et al. (2015) Protein profile of exhaled breath condensate determined by high resolution mass spectrometry. J. Pharm. Biomed. Anal., 105, 134–149. [DOI] [PubMed] [Google Scholar]
  • 171.Hayes S.A., Haefliger S., Harris B.. et al. (2016) Exhaled breath condensate for lung cancer protein analysis: a review of methods and biomarkers. J. Breath Res., 10, 034001. [DOI] [PubMed] [Google Scholar]
  • 172.Lacombe M., Marie-Desvergne C., Combes F.. et al. (2018) Proteomic characterization of human exhaled breath condensate. J. Breath Res., 12, 021001. [DOI] [PubMed] [Google Scholar]
  • 173.Chen D.P., Bryden W.A. and Mcloughlin M. (2020) A novel system for the comprehensive collection of nonvolatile molecules from human exhaled breath. J. Breath Res., 15, 016001. [DOI] [PubMed] [Google Scholar]
  • 174.Gade I.L., Schultz J.G., Cehofski L.J.. et al. (2020) Exhaled breath condensate in acute pulmonary embolism; a porcine study of effect of condensing temperature and feasibility of protein analysis by mass spectrometry. J. Breath Res., 15, 026005. [DOI] [PubMed] [Google Scholar]
  • 175.Paulo J.A., Lee L.S., Banks P.A.. et al. (2011) Difference gel electrophoresis identifies differentially expressed proteins in endoscopically collected pancreatic fluid. Electrophoresis, 32, 1939–1951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 176.Paulo J.A., Lee L.S., Wu B.. et al. (2010) Identification of pancreas-specific proteins in endoscopic (ePFT) collected pancreatic fluid with mass spectrometry (GeLC-MS/MS). Pancreas, 39, 889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 177.Marchegiani G., Paulo J.A., Sahora K.. et al. (2015) The proteome of postsurgical pancreatic juice. Pancreas, 44, 574–582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 178.Paulo J.A., Kadiyala V., Gaun A.. et al. (2013) Analysis of endoscopic pancreatic function test (ePFT)-collected pancreatic fluid proteins precipitated via ultracentrifugation. J. Pancreas, 14, 176–186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 179.Csősz É., Emri G., Kalló G.. et al. (2015) Highly abundant defense proteins in human sweat as revealed by targeted proteomics and label-free quantification mass spectrometry. J. Eur. Acad. Dermatol. Venereol., 29, 2024–2031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 180.Raiszadeh M.M., Ross M.M., Russo P.S.. et al. (2012) Proteomic analysis of eccrine sweat: implications for the discovery of schizophrenia biomarker proteins. J. Proteome Res., 11, 2127–2139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 181.Yu Y.J., Prassas I., Muytjens C.. et al. (2017) Proteomic and peptidomic analysis of human sweat with emphasis on proteolysis. J. Proteomics, 155, 40–48. [DOI] [PubMed] [Google Scholar]
  • 182.Johnson M., Zaretskaya I., Raytselis Y.. et al. (2008) NCBI BLAST: a better web interface. Nucleic Acids Res., 36, W5–W9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 183.Maere S., Heymans K. and Kuiper M. (2005) BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics, 2, 3448–3449. [DOI] [PubMed] [Google Scholar]
  • 184.Shannon P., Markiel A., Ozier O.. et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res., 13, 2498–2504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 185.Cui J., Liu Q., Puett D.. et al. (2008) Computational prediction of human proteins that can be secreted into the bloodstream. Bioinformatics, 24, 2370–2375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 186.Hong C.S., Cui J., Ni Z.H.. et al. (2011) A computational method for prediction of excretory proteins and application to identification of gastric cancer markers in urine. PLoS One, 6, e16875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 187.Hu L.L., Huang T., Cai Y.D.. et al. (2011) Prediction of body fluids where proteins are secreted into based on protein interaction network. PLoS One, 6, e22989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 188.Liu Q., Cui J., Yang Q.. et al. (2010) In-silico prediction of blood-secretory human proteins using a ranking algorithm. BMC Bioinform., 11, 250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 189.Sun Y., Du W., Zhou C.. et al. (2015) A computational method for prediction of saliva-secretory proteins and its application to identification of head and neck cancer biomarkers for salivary diagnosis. IEEE Trans. Nanobiosci., 14, 167–174. [DOI] [PubMed] [Google Scholar]
  • 190.Wang J.X., Liang Y.C., Wang Y.. et al. (2013) Computational prediction of human salivary proteins from blood circulation and application to diagnostic biomarker identification. PLoS One, 8, e80211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 191.Wang Y., Du W., Liang Y.C.. et al. (2016) PUEPro: a computational pipeline for prediction of urine excretory proteins. In: 2016 Advanced Data Mining and Applications (ADMA). Gold Coast, QLD, Australia. [Google Scholar]

Articles from Database: The Journal of Biological Databases and Curation are provided here courtesy of Oxford University Press

RESOURCES